郭于誠 Yu-Cheng Kuo 主治醫師
郭于誠醫師專長為肝膽腸胃道腫瘤之放射治療、泌尿道癌之放射治療、全身立體定位放射治療。郭醫師畢業於高雄醫學大學，曾任彰化秀傳醫院放射腫瘤科主任、癌症中心主任及醫學教育部部主任。現為台灣硼中子捕獲治療學會理事及台灣放射腫瘤學會副祕書長。專精肝膽腸胃道腫瘤與泌尿道癌之放射治療。
學術機構典藏
論文
期刊論文
|
期刊論文／Journal Paper (作者群，論文題目，期刊名稱，出版年月，卷號(期別):頁次起迄) |
日期 | |
| 1 | (Chun-Min Su)、(Hsiao-Chia Wang)、許斐婷(Hsu, Fei-Ting)、(Chun-Hui Lu)、(CHIEN-KAI LAI)、鍾景光(Jing-Gung Chung)、郭于誠(Yu-Cheng Kuo)*，Astragaloside IV induces apoptosis, G1 phase arrest and inhibits anti-apoptotic signaling in hepatocellular carcinoma，IN VIVO，2020 Mar，34(2):631-638 | 2020 . 03 |
| 2 | 許斐婷(Hsu, Fei-Ting)、蔣宜蒼(I-Tsang Chiang)、郭于誠(Yu-Cheng Kuo)、(Te-Chun Hsia)、(Chin-Chung Lin)、劉育昌(Yu-Chang Liu)、鍾景光(Jing-Gung Chung)*，Amentoflavone Effectively Blocked the Tumor Progression of Glioblastoma via Suppression of ERK/NF-kB Signaling Pathway，AMERICAN JOURNAL OF CHINESE MEDICINE，2019 May，47(4):1-19 | 2019 . 05 |
| 3 | 吳偉榤(WU WEI-CHIEH)、張宜儒(Chang, Yi-Ru)、賴宥良(Yo-Liang Lai)、蕭安成(An-Cheng Shiau)*、梁基安(Ji-An Liang)、簡君儒(Chun-Ru Chien)、郭于誠(Yu-Cheng Kuo)、陳尚文(Shang-Wen Chen)*，Impact of body-mass factors on setup displacement during pelvic irradiation in patients with lower abdominal cancer，Radiology and Oncology，2019 Apr，0017(): | 2019 . 04 |
| 4 | (KUN-CHING LEE)、(JAI-JEN TSAI)、(CHIH-WEI TSENG)、郭于誠(Yu-Cheng Kuo)、(YAO-CHEN CHUANG)、(SONG-SHEI LIN)*、許斐婷(Hsu Fei-Ting)*，Amentoflavone Inhibits ERK-Modulated Tumor Progression in Hepatocellular Carcinoma In Vitro，IN VIVO，2018 May，32(3):549-554 | 2018 . 05 |
| 5 | 翁茂琦(Mao-Chi Weng)、王惠美(Mei-Hui Wang)、蔡佳珍(Jai-Jen Tsai)、郭于誠(Yu-Cheng Kuo)、劉育昌(Yu-Chang Liu)、許斐婷(Hsu Fei-Ting)*、王信二(Hsin-Ell Wang)*，Regorafenib inhibits tumor progression through suppression of ERK/NF-κB activation in hepatocellular carcinoma bearing mice，BIOSCIENCE REPORTS，2018 May，38(3): | 2018 . 05 |
| 6 | 蔡佳珍(JAI-JEN TSAI)、許斐婷(Hsu Fei-Ting)、(PO-JUNG PAN)、(CHIA-WEN CHEN)、郭于誠(Yu-Cheng Kuo)*，Amentoflavone Enhances Therapeutic Efficacy of Sorafenib by Inhibiting Anti-apoptotic Potential and Potentiating Apoptosis in Hepatocellular Carcinoma In Vivo，ANTICANCER RESEARCH，2018 Apr，38(4):2119-2125 | 2018 . 04 |
| 7 | (WEI?LUNG CHEN)、(CHIA?LING HSIEH)、(JIANN?HWA CHEN)、(CHIH?SHENG HUANG)、(WEI?TING CHEN)、郭于誠(Yu-Cheng, Kuo)、(CHENG?YU CHEN)、(FEI?TING HSU)*，Amentoflavone enhances sorafenib-induced apoptosis through extrinsic and intrinsic pathways in sorafenib-resistant hepatocellular carcinoma SK-Hep1cells in vitro，Oncology Letters，2017 Sep，14():3229-3234 | 2017 . 09 |
| 8 | (Wei-Lung Chen)、(Chia-Ling Hsieh)、(Jiann-Hwa Chen)、(Chih-Sheng Huang)、(Wei-Ting Chen)、郭于誠(Yu-Cheng Kuo)、陳震宇(Cheng-Yu Chen)*、許斐婷(Hsu Fei-Ting)*，Amentoflavone enhances sorafenib-induced apoptosis through extrinsic and intrinsic pathways in sorafenib-resistant hepatocellular carcinoma SK-Hep1 cells in vitro，Oncology Letters，2017 Sep，14(3):3229-3234 | 2017 . 09 |
| 9 | (I-TSANG CHIANG)、(WEI-TING CHEN)、(CHIH-WEI TSENG)、(YEN-CHUNG CHEN)、郭于誠(Yu-Cheng, Kuo)、(BI-JHIH CHEN)、(MAO-CHI WENG)、(HWAI-JENG LIN)*、(WEI-SHU WANG)*，Hyperforin Inhibits Cell Growth by Inducing Intrinsic and Extrinsic Apoptotic Pathways in Hepatocellular Carcinoma Cells，ANTICANCER RESEARCH，2017 Jan，37():161-168 | 2017 . 01 |
| 10 | 林淑捐(Shwu-Jiuan Lin)、(Ta-Chi Su)、朱俊男(Chu, Chin-Nan)、張益銍(Yi-Chih, Chang)、楊禮明(Li-Ming Yang)、郭于誠(Yu-Cheng, Kuo)*、黃琮竣(Tsurng-Juhn Huang)*，Synthesis of C-4 Substituted Steviol Derivatives and Their Inhibitory Effects against Hepatitis B Virus，JOURNAL OF NATURAL PRODUCTS，2016 Dec，79(12):3057-3064 | 2016 . 12 |
| 11 | 賴宥良(Yo-Liang Lai)、郭于誠(Yu-Cheng, Kuo)、賴學洲(Hsueh-Chou Lai)、彭成元(Cheng-Yuan Peng)、王耀慶(Yao-Ching Wang)、梁基安(Liang, Ji-An)、陳尚文(Shang-Wen Chen)*，Early radiation-induced liver toxicities are associated with poor survival in patients with advanced hepatocellular carcinoma，Asia-Pacific Journal of Clinical Oncology，2016 Dec，12(4):437-443 | 2016 . 12 |
| 12 | 李芃逸(Peng-Yi Lee)、簡君儒(Chien, Chun-Ru)、陳自諒(Chen, William Tzu-Liang)、柯道維(TAO-WEI KE)、郭于誠(Yu-Cheng, Kuo)、張伸吉(Sheng-Chi Chang)、林膺峻(Ying-Chun Lin)，Treatment outcomes of neoadjuvant CCRT in patients with locally advanced rectal cancer- A single institutional report，放射治療與腫瘤學，2016 Jun，23(2):85-97 | 2016 . 06 |
| 13 | 黃映霈(Ying-Pei Huang)、(Hong-Pin Shih)、(Yu-Chuan Liang)、(Hui-Hsien Lin)、(Ming-Chun Lin)、陳嘉雯(Chia-Wen Chen)、黃琮竣(Tsurng-Juhn Huang)*、郭于誠(Yu-Cheng, Kuo)、(Chien-Chung Han)*、(Ming-Hua Hsu)*，Advanced Generation of Paeonol-Phenylsufonyl Derivatives As Potential Anti-HBV Agents，RSC Advances，2016 Apr，(): | 2016 . 04 |
| 14 | 黃琮竣(Tsurng-Juhn Huang)、楊承琳(Cheng-Lin Yang)、郭于誠(Yu-Cheng, Kuo)、張益銍(Yi-Chih, Chang)、楊禮明(Li-Ming Yang)、周伯宏(Bo-Hon Chou)、林淑娟(Shwu-Jiuan Ling)*，Synthesis and anti-hepatitis B virus activity of C4 amide-substituted isosteviol derivatives，BIOORGANIC & MEDICINAL CHEMISTRY，2015 Mar，23():720-728 | 2015 . 03 |
| 15 | 黃琮竣(Tsurng-Juhn Huang)、(Hong Chuang)、(Yu-Chuan Liang)、(Hui-Hsien Lin)、(Jia-Cherng Horng)、郭于誠(Yu-Cheng, Kuo)、陳嘉雯(Chia-Wen Chen)、(Fu-Yuan Tsai)、(Shih-Chieh Yen)、(Shih-Ching Chou)、(Ming-Hua Hsu)*，Design, Synthesis, and Bioevaluation of Paeonol Derivatives as Potential Anti-HBV Agents，EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY，2015 Jan，90():428-435 | 2015 . 01 |
| 16 | 黃琮竣(Tsurng-Juhn Huang)*、(Yu-Chi Tsai)、(Shang-Yu Chiang)、汪貴珍(Guei-Jane Wang)、郭于誠(Yu-Cheng, Kuo)、張益銍(Yi-Chih, Chang)、吳怡瑩(WU YI-YING)、吳永昌(Yang-Chang Wu)*，Anti-viral effect of a compound isolated from Liriope platyphylla against hepatitis B virus in vitro，VIRUS RESEARCH，2014 Jul，192(**):16-24 | 2014 . 07 |
| 17 | 陳尚文(Shang-Wen Chen)、林立青(Li-Ching Lin)、郭于誠(Yu-Cheng, Kuo)、梁基安(Ji-An Liang)、郭嘉駿(Chia-Chun Ku)、邱仲峰(Jeng-Fong Chiou)*，Phase 2 Study of Combined Sorafenib and Radiation Therapy in Patients With Advanced Hepatocellular Carcinoma，INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS，2014 Mar，88(5):1041-1047 | 2014 . 03 |
| 18 | 陳嘉雯(Chia-Wen Chen)、林則成、陳坤堡(Kuen-Bao Chen)、郭于誠(Yu-Cheng, Kuo)、李繼源(Chi-Yuan Li)*、鍾季容(Chi-Jung Chung)*，Increased risk of dementia in people with previous exposure to general anesthesia: A nationwide population-based case–control study，Alzheimers & Dementia，2014 Mar，10(2014):196-204 | 2014 . 03 |
| 19 | 陳嘉雯(Chia-Wen Chen)、林維勇(Wei-Yong Lin)、陳坤堡(Kuen-Bao Chen)、吳翌玄(Yih-Shyuan Wu)、郭于誠(Yu-Cheng, Kuo)、劉心萍(Hsin-Ping Liu)*、李繼源(Chi-Yuan Li)*，Inhalational Anesthetic Sevoflurane Rescues Retina Function in Alzheimer’s Disease Transgenic Drosophila.，Current Alzheimer Research，2013 Nov，10(9):1005-1014 | 2013 . 11 |
| 20 | 黃琮竣(Tsurng-Juhn Huang)、劉書亨(Shu-Heng Liu)、郭于誠(Yu-Cheng, Kuo)、陳嘉雯(Chia-Wen Chen)、周聖杰(Shen-Chieh Chou)*，Antiviral activity of chemical compound isolated from Artemisia morrisonensis against hepatitis B virus in vitro，ANTIVIRAL RESEARCH，2013 Nov，101():97-104 | 2013 . 11 |
| 21 | 陳嘉雯(Chia-Wen Chen)、黃鐙樂(Teng-Le Huang)、蘇莉婷(Li-Ting Su)、郭于誠(Yu-Cheng, Kuo)、吳世銓(Rick Sai-Chuen Wu)、李繼源(Chi-Yuan Li)、陳坤堡(Kuen-Bao Chen)、宋鴻樟(Fung-Chang Sung)*，Incidence of Subsequent Hip Fractures is Significantly Increased within the First Month after Distal Radius Fracture in Patients over 60 Years Old，JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE，2013 Jan，74(1):317-321 | 2013 . 01 |
| 22 | 陳嘉雯(Chia-Wen Chen)、林維勇(Wei-Yong Lin)、吳翌玄(Yih-Shyuan Wu)、陳坤堡(Kuen-Bao Chen)、劉心萍(Hsin-Ping Liu)、郭于誠(Yu-Cheng, Kuo)、李繼源(Chi-Yuan Li)*，SEVOFLURANE RESCUES THE ELETRORETINOGRAM OF ALZHEIMER’S TRANSGENIC DROSOPHILA，Alzheimers & Dementia，2012 Jul，8(4 Suppl):638-638 | 2012 . 07 |
| 23 | 郭于誠(Yu-Cheng, Kuo)、林緯展(Wei-Chan Lin)、(I-Tsang Chiang)、(Ya-Fang Chang)、陳嘉雯(Chia-Wen Chen)、(Shih-Hao Su)、(Chuan-Lin Chen)、黃正仲(Jeng-Jong Hwang)*，Sorafenib Sensitizes Human Colorectal Carcinoma to Radiation via Suppression of NF-kB Expression in Vitro and in Vivo，BIOMEDICINE & PHARMACOTHERAPY，2012 Jan，(): | 2012 . 01 |
| 24 | 簡君儒(Chun-Ru Chien)、林香汶(Margaret Hsiang-Wen Lin)、(Yang, C.-H)、楊世能(Shih-Neng Yang)、王耀慶(Yao-Ching Wang)、郭于誠(Yu-Cheng, Kuo)、陳尚文(Shang-Wen Chen)*、梁基安(Ji-An Liang)*，High case volume of radiation oncologists is associated with better survival of nasopharyngeal carcinoma patients treated with radiotherapy: a multifactorial cohort analysis，CLINICAL OTOLARYNGOLOGY，2011 Dec，36(1):558-565 | 2011 . 12 |
| 25 | 林士捷(Shih-Chieh Lin)、楊世能(Shih-Neng Yang)、王耀慶(Yao-Ching Wang)、梁基安(Ji-An Liang)、郭于誠(Yu-Cheng, Kuo)、林芳仁(Fang-Jen Lin)、陳尚文(Shang-Wen Chen)*，Clinical Implications of Tumor Volume in Patients with the Base of Tongue Cancer Treated with Definitive Intensity-Modulated Radiotherapy Technique，放射治療與腫瘤學，2011 Oct，18(3):193-204 | 2011 . 10 |
| 26 | 郭于誠(Yu-Cheng, Kuo)、邱瑩明(Ying-Ming, Chiu)、施文彬(Wen-Pin Shih)、余孝緯(Hsiao-Wei Yu)、陳嘉雯(Chia-Wen Chen)、翁培峰(Pei-Fong, Wong)、林緯展(Wei-Chan, Lin)、黃正仲(Jeng-Jong, Hwang)*，Volumetric Intensity-Modulated Arc (RapidArc) Therapy for Primary Hepatocellular carcinoma: Comparison with Intensity-Modulated Radiotherapy and 3-D Conformal Radiotherapy，Radiation Oncology，2011 Jun，6(76):2-9 | 2011 . 06 |
| 27 | 李怡慧(Yi-Hui Lee)、陳坤堡(Kuen-Bao Chen)、郭于誠(Yu-Cheng, Kuo)、簡吉聰(Chi-Tsung Chien)、陳嘉雯(Chia-Wen Chen)*，A Simple Method to Improve the Safety and Comfort of Anesthesia for Deep Brain Stimulation: Case Report and Literature Review，NEUROSURGERY QUARTERLY，2011 May，21(2):107-109 | 2011 . 05 |
| 28 | 陳嘉雯(Chia-Wen Chen)、吳憬全(King-Chuen Wu)、郭于誠(Yu-Cheng, Kuo)、江易穎(Yi-Ying Chiang)、吳世銓(Rick Sai-Chuen Wu)*，Local anesthetic infiltration to the trachea facilitates spontaneous ventilation in a patient with giant lung bullae undergoing an emergent non-pulmonary surgery，麻醉學雜誌，2010 Dec，48(4):194-195 | 2010 . 12 |
| 29 | 林玉娟(Yu-Chuan Lin)、陳虹文(Hong-Wen Chen)、郭于誠(Yu-Cheng, Kuo)、張雅芳(Ya-Fang Chang)、李易展(Yi-Jang Lee)*、黃正仲(Jeng-Jong Hwang)*，Therapeutic Efficacy Evaluation of Curcumim on Human Oral Squamous Cell Carcinoma Xenograft Using Multimodalities of Molecular Imaging，AMERICAN JOURNAL OF CHINESE MEDICINE，2010 May，38(2):343-358 | 2010 . 05 |
| 30 | 廖愛禾(A.H. Liao)、(F.I. Chou)、郭于誠(Yu-Cheng, Kuo)、(H.W. Chen)、(J.J. Kai)、(C.W. Chang)、(F.D. Chen)、黃正仲(J.J. Hwang)*，Biodistribution of phenylboric acid derivative entrapped lipiodol and 4-borono-2-18F-fluoro-L-phenylalanine-fructose in GP7TB liver tumor bearing rats for BNCT，APPLIED RADIATION AND ISOTOPES，2010 Mar，68(3):422-426 | 2010 . 03 |
| 31 | 李志明、梁庭繼、張君照、郭于誠(Yu-Cheng, Kuo)、邱仲峰、王鴻蓉、陳雅妍，Effect of Silymarin on Hepatic Function of Patients with Unresectable Hepatocellular Carcinoma After Transcatheter Hepatic Arterial Chemoembolization，中華放射線醫學雜誌，2008 Sep，33(3):137-141 | 2008 . 09 |
| 32 | 郭于誠(Yu-Cheng, Kuo)、吳東和(Tung-Ho Wu)、鍾道生(Chung TS)、黃光偉(Kuang-Wei Huang)、趙坤山(K. S. Clifford Chao)、蘇文川(Wen-Chuan Su)、邱仲峰(Jeng-Fong Chiou)*，Effect of Regression of Enlarged Neck Lymph Nodes on Radiation Doses Received by Parotid Glands During Intensity-Modulated Radiotherapy for Head and Neck Cancer，AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS，2006 Dec，29(6):600-605 | 2006 . 12 |
研討會論文
|
研討會論文／Conference Papers (發表主題或論文名稱，研討會名稱，演講地點，研討會期間，受邀演講題目) |
日期 | |
| 1 | Oligo-progressive status exhibits unfavorable survival in pulmonary oligo-recurrence treated by SABR，ESTRO 38，Milan, Italy，2019.04.26~2019.04.30， | 2019 . 04 |
| 2 | ，2019台灣中子捕獲治療研究學會年會，台北，2019.01.12~2019.01.12，Salvage BNCT for recurrent nasopharyngeal carcinoma: A case report | 2019 . 01 |
| 3 | Using multimodality imaging to evaluate anti-cancer effect and mechanism of regorafenib in hepatocellular carcinoma in vitro and in vivo，World Molecular Imaging Congress 2018，Seattle, WA，2018.09.12~2018.09.15， | 2018 . 09 |
| 4 | Controversy in Anti-epileptic Drug as Radio-Sensitizer to Improve Survival in High Grade Malignant Glioma: A Nationwide Population-Based Cohort Study，The 59th Annual Meeting of ASTRO，San Diego Convention Center, San Diego, CA, USA，2017.09.24~2017.09.27， | 2017 . 09 |
| 5 | General Anesthesia and Parkinson’s Disease，INTERNATIONAL CONGRESS OF PARKINSON'S DISEASE AND MOVEMENT DISORDERS 2017，VANCOUVER, CANADA，2017.06.04~2017.06.08， | 2017 . 06 |
| 6 | Analysis of class I Integron from multiple drug resistance Acinetobacter baumanni in clinical isolates，第九屆中國醫藥大學暨亞洲大學生物科技研討會，中國醫藥大學立夫教學大樓B1國際會議廳，2016.03.14~2016.03.14， | 2016 . 03 |
| 7 | Antimicrobial activity of synthetic analogues (Hsu-48 drug) against the emergence of antimicrobial resistance MRSA and coagulase-negative Staphylococci，第九屆中國醫藥大學暨亞洲大學生物科技研討會，中國醫藥大學立夫教學大樓B1國際會議廳，2016.03.14~2016.03.14， | 2016 . 03 |
| 8 | Antimicrobial susceptibility of Hsu-48 drug against the emergence of antimicrobial resistance beta-hemolytic streptococci in clinical isolates，第九屆中國醫藥大學暨亞洲大學生物科技研討會，中國醫藥大學立夫教學大樓B1國際會議廳，2016.03.14~2016.03.14， | 2016 . 03 |
| 9 | Antimicrobial activity of Hsu-48 drug (a new nordihydroguaiaretic acid derivative) in clinical emergency pathogens，台灣微生物學會第二十一屆第三次台灣微生物學會年會暨會員大會，台北國際會議中心，2015.10.17~2015.10.17， | 2015 . 10 |
| 10 | ，The 3rd Japan-Taiwan Radiation Oncology Symposium，yamanashi，2015.06.27~2015.06.28，Preliminary Results of Neoadjuvant CCRT in Locally Advanced Rectal Cancer in CMUH | 2015 . 06 |
| 11 | The interval less then one month between TACE and subsequent hepatic RT dose not contribute to an increased risk of radiation-induced liver disease.，第二十屆台灣癌症聯合學術年會，台北榮民總醫院，2015.05.02~2015.05.03， | 2015 . 05 |
| 12 | TREATMENT OUTCOMES OF NEOADJUVANT CCRT IN PATIENTSWITH LOCALLY ADVANCED RECTAL CANCER，2015 The 20th Taiwan Joint Cancer Conference，Taipei, Taiwan，2015.05.02~2015.05.03， | 2015 . 05 |
| 13 | Sevoflurane May Not Induce Long-term Toxicity On Spinocerebellar Ataxia Type 3 Transgenic Drosophila Model，IARS 2015 Annual Meeting and International Science Symposium，Hawaii, Honolulu, USA，2015.03.21~2015.03.24， | 2015 . 03 |
| 14 | 丹皮酚衍生物促進巨噬細胞分化為蝕骨細胞，2014年免疫學會會員大會暨學術演講會，台灣大學醫學院一樓102、103、104講堂，2014.10.19~2014.10.19， | 2014 . 10 |
| 15 | RANK ligand 誘導 Monocyte/ Macrophages Lineag前驅細胞蝕骨細胞的分化會被NC- 8所抑制，2014年中華民國免疫學會會員大會暨學術演講會，台灣大學醫學院一樓102、103、104講堂，2014.10.19~2014.10.19， | 2014 . 10 |
| 16 | MELD Score Is a Predictor of Early Deterioration of Liver Function and Overall Survival in Patients with Hepatocellular Carcinoma Receiving Radiation Therapy，ASTRO’s 56th Annual Meeting，Moscone Center, San Francisco，2014.09.14~2014.09.17， | 2014 . 09 |
| 17 | NC-8 inhibits the osteoclast differentiation from Monocyte/ Macrophages Lineage precursor cell.，第七屆生物科技研討會，本校國際會議廳，2014.05.14~2014.05.14， | 2014 . 05 |
| 18 | Sevoflurane may not affect the survival in a Drosophila Parkinson's disease model，5th NWAC World Anesthesia Convention Networking，Vienna, Austria，2014.04.30~2014.05.03， | 2014 . 04 |
| 19 | Sevoflurane may not affect the survival in a Drosophila Parkinson's disease model，5th NWAC 2014，Vienna, Austria，2014.04.30~2014.05.03， | 2014 . 04 |
| 20 | Sevoflurane may not affect the survival in a Drosophila Parkinson's disease model，5th NWAC 2014，Vienna, Austria，2014.04.30~2014.05.03， | 2014 . 04 |
| 21 | Antiviral activity of chemical compound isolated from Artemisia morrisonensis against hepatitis B virus in vitro，23rd Conference of the Asian Pacific Association for the Study of the Liver (APASL)，Brisbane, Australia，2014.03.12~2014.03.15， | 2014 . 03 |
| 22 | Antiviral activity of chemical compound isolated from Artemisia morrisonesis against hepatitis B virus in vitro，23rd Conference of the Asian Pacific Association for the Study of the Liver，Brisbane, Australia，2014.03.12~2014.03.15， | 2014 . 03 |
| 23 | Menstrual Cycle Phase Modulates Pain-Related Brain’s Functional Networks，32st Annual ESRA Congress 2013，Glasgow，United Kingdom，2013.09.04~2013.09.07， | 2013 . 09 |
| 24 | To evaluate the efficacy of re-irradiation to patients with recurent or residual esophageal cancer after CCRT or RT alone-CMUH experience，第十八屆台灣癌症聯合學術年會，台大醫院國際會議中心，2013.07.13~2013.07.14， | 2013 . 07 |
| 25 | Sevoflurane May Not Exacerbate the Eye Phenotype in Alzheimer’s Disease Transgenic Drosophila，Alzheimer's Association International Conference 2013，Boston, USA，2013.07.13~2013.07.18， | 2013 . 07 |
| 26 | Sevoflurane May Not Induce Long-term Toxicity in Alzheimer’s Disease Transgenic Drosophila，IARS 2013 Annual meeting，San Diego, USA，2013.05.04~2013.05.07， | 2013 . 05 |
| 27 | 山奈酚治療肺癌以及作為放射增敏劑之探討，2013年中華民國生醫材料及藥物制放年會暨國科會醫工學門成果發表會，義守大學，2013.05.04~2013.05.05， | 2013 . 05 |
| 28 | An Old Man Who Received Aorto-Superior Mesenteric Artery Bypass plus T10-L2 Laminectomy under General Anesthesia，2012 Annual Scientific Meeting of Taiwan Pain Society，國立成功大學醫學院，2012.03.10~2012.03.11， | 2012 . 03 |
| 29 | Negative Pressure Pulmonary Edema after Laparoscopic Cholecystectomy in a Patient with Laryngeal Cancer，2011 Annual Meeting of TSCCC in conjunction with the 14th Congres of PENSA，台北圓山飯店，2011.10.14~2011.10.16， | 2011 . 10 |
| 30 | Sorafenib Sensitizes Human Colorectal Carcinoma to Radiation via Suppression of NF-kB Expression，2011 World Molecular Imaging Congress，Convention Center, San Diego, California, USA，2011.09.07~2011.09.10， | 2011 . 09 |
| 31 | 蕾莎瓦抑制輻射誘發肝癌細胞之輻射抗性是經由阻斷NF-kB及其相關蛋白之表現，第十六屆台灣癌症聯合學術年會暨第十屆海峽兩岸腫瘤學術會議，國防醫學院3F，2011.04.30~2011.05.01， | 2011 . 04 |
| 32 | 使用RapidArc 治療肝癌與IMRT 及3DCRT 之劑量比較，第十六屆台灣癌症聯合學術年會暨第十屆海峽兩岸腫瘤學術會議，國防醫學院3F，2011.04.30~2011.05.01， | 2011 . 04 |
| 33 | Clinical Implications of Tumor Volume in Patients with the Base of Tongue Cancer Treated with Definitive Intensity-Modulated Radiotherapy Technique，2010 The 15 th Taiwan Joint Cancer Conference，三軍總醫院，2010.05.01~2010.05.02， | 2010 . 05 |
| 34 | 對於一位有雙側巨大肺氣腫的病人進行緊急剖腹探查，中華民國重症醫學會第四屆第三次會員大會暨學術演講會，三軍總醫院 B1 第一.三.五演講廳，2009.10.17~2009.10.18， | 2009 . 10 |
| 35 | Tomotherapy in Palliating Multiple Painful Bone Metastases from Hepatocellular carcinoma (HCC)，2009台灣麻醉醫學會年會暨學術研討會，中國醫藥大學立夫教學大樓，2009.09.26~2009.09.27， | 2009 . 09 |
| 36 | A Local Anesthetics Infiltration Method Facilitates Airway Securing in Deep Brain Stimulation for Parkinson’s Disease，2009台灣麻醉醫學會年會暨學術研討會，中國醫藥大學立夫教學大樓，2009.09.26~2009.09.27， | 2009 . 09 |
| 37 | Preliminary treatment outcome of intensity modulated radiotherapy with or without chemotherapy for nasopharyngeal carcinoma，第十四屆台灣癌症聯合醫學會暨第八屆海峽兩岸腫瘤學術會議，國防醫學院3F，2009.05.02~2009.05.03， | 2009 . 05 |
| 38 | Therapeutic Evaluation of Sorafenib Combined with X-ray Irradiation of HT-29/tk-luc Colorectal cancer cell Line: In vivo and in vitro Studies-Preliminary Results，2008 World Molecular Imaging Congress，Nice, France，2008.09.10~2008.09.13， | 2008 . 09 |
| 39 | Therapeutic Evaluation of Sorafenib Combined with X-ray Irradiation of HT-29/tk-luc Colorectal cancer cell Line: In vivo and in vitro Studies-Preliminary Results，2008 World Molecular Imaging Congress，Nice , France，2008.09.10~2008.09.13， | 2008 . 09 |
| 40 | 針對大型肝腫瘤以強度調控放射線治療與三度順形放射線治療的正常組織併發症機率比較，第十三屆台灣癌症聯合學術年會，國防醫學院，2008.05.03~2008.05.04， | 2008 . 05 |
專書
暫無資料研究計畫
|
研究計畫／Research Grant (研究類型，研究計畫代號，主持人，補助或委託單位名稱，計畫名稱，計畫期間) |
日期 | |
| 1 | 個別型，DMR-110-071，許斐婷(Hsu, Fei-Ting)，附醫院內計畫，樂衛瑪合併穗花雙黃酮於肝癌細胞之療效與機制探討，2020.8.1~2021.7.31 | 2020 . 08 |
| 2 | 個別型，MOST 107-2314-B-039-024-，楊安綏(Yang, An-Suei)、楊世能(Shih-Neng Yang)、郭于誠(Yu-Cheng Kuo)、黃群偉(Huang, Chiun-Wei)，科技部，建立預測及評估免疫檢查點抑制劑療效之影像平台，2018.8.1~2019.7.31 | 2018 . 08 |
| 3 | 臨床試驗與研究計畫，CMUH104-REC1-116，梁基安(Liang, Ji-An)、陳汶吉(Chen, Wen-Chi)、陳冠亨(Guang-Heng Chen)、楊啟瑞(Yang, Che-Rei)、黃志平(Huang, Chi-Ping)、謝博帆(Po-Fan Hsieh)、葉進仲(Yeh, Chin-Chung)、郭于誠(Yu-Cheng, Kuo)，附醫廠商計畫，接受主要放射線療法之高風險、局限性或局部晚期攝護腺癌受試者使用JNJ-56021927的一項隨機分配、雙盲、安慰劑對照第3期研究，2017.1.1~2017.12.31 | 2017 . 01 |
| 4 | 臨床試驗與研究計畫，CMUH104-REC1-116，梁基安(Ji-An Liang)、陳汶吉(Chen, Wen-Chi)、陳冠亨(Guang-Heng Chen)、楊啟瑞(Che-Rei Yang)、 黃志平、謝博帆(Po-Fan Hsieh)、葉進仲(Yeh, Chin-Chung)、郭于誠(Yu-Cheng, Kuo)，附醫廠商計畫，接受主要放射線療法之高風險、局限性或局部晚期攝護腺癌受試者使用JNJ-56021927的一項隨機分配、雙盲、安慰劑對照第3期研究，2016.1.1~2016.12.31 | 2016 . 01 |
| 5 | 個別型，DMR-104-039，黃琮竣(Tsurng-Juhn Huang)，附醫院內計畫，以離體試驗評估丹皮酚衍生化合物抑制放射治療誘發肝癌細胞中B型肝炎病毒之再活化機制，2014.8.1~2015.7.31 | 2014 . 08 |
| 6 | 個別型，DMR-103-042，黃琮竣(Tsurng-Juhn Huang)，附醫院內計畫，以肝癌細胞離體試驗以評估異甜菊醇衍生化合物抑制放射治療誘發之B型肝炎病毒再活化機制，2013.8.1~2014.7.31 | 2013 . 08 |
| 7 | 個別型，NSC 102-2314-B-039-017-，李繼源(Chi-Yuan Li)、林維勇(Wei-Yong Lin)、陳坤堡(Kuen-Bao Chen)、郭于誠(Yu-Cheng, Kuo)、吳柏蒼(Bor-Tsang Wu)，科技部，利用果蠅動物模式研究吸入性麻醉藥在神經退化性疾病的影響與分子機制II，2013.8.1~2014.7.31 | 2013 . 08 |
| 8 | 個別型，NSC 102-2221-E-039-006，，科技部，放射電腦斷層治療儀導航影像劑量最適化，2013.8.1~2014.7.31 | 2013 . 08 |
| 9 | 個別型，NSC 101-2314-B-039-006，李繼源(Chi-Yuan Li)、林維勇(Wei-Yong Lin)、陳坤堡(Kuen-Bao Chen)、郭于誠(Yu-Cheng, Kuo)、吳柏蒼(Bor-Tsang Wu)，科技部，利用果蠅動物模式研究吸入性麻醉藥在神經退化性疾病的影響與分子機制，2012.9.1~2013.7.31 | 2012 . 09 |
| 10 | 個別型，DMR-100-061，黃正仲(Jeng Jong Hwang)，附醫院內計畫，探討Sorafenib是否可以經由抑制NF-kB活性以提升人類大腸直腸癌之放射線敏感度，2010.7.1~2011.8.31 | 2010 . 07 |
| 11 | 個別型，DMR-98-143，黃正仲(J.J Huang)、梁基安(Ji-An Liang)、郭于誠(Yu-Cheng, Kuo)、陳嘉雯(Chia-Wen Chen)，附醫院內計畫，利用分子影像技術探討Curcumin合併放射線治療對於SAS/luc人類口腔癌細胞的療效評估，2009.2.1~2009.12.31 | 2009 . 02 |
| 12 | 個別型，DMR-98-145，梁基安(Ji-An Liang)、郭于誠(Yu-Cheng, Kuo)，附醫院內計畫，111In-NanoVNB對於HT-29/tk-luc人類大腸直腸癌細胞的療效評估，2009.2.1~2009.12.31 | 2009 . 02 |
| 13 | 個別型，DMR-98-127，黃正仲(Jeng Jong Huang)、梁基安(Ji-An Liang)、陳嘉雯(Chia-Wen Chen)，附醫院內計畫，以多種分子影像技術探討Sorafenib合併放射線治療對於HepG2/tk-luc人類肝癌細胞的療效評估，2008.8.1~2009.6.30 | 2008 . 08 |